diabetes

Is MannKind a Bad News Buy?
Motley Fool
Sat, 11/6/10 - 12:59 pm
MannKind
inhaled insulin
Afrezza
diabetes
MannKind Falls After Lawsuit Alleges Unlawful Clinical Trial Conduct
Bloomberg
Thu, 11/4/10 - 10:00 pm
MannKind
lawsuits
diabetes
fraud
Afrezza
MannKind Accused of Data Fraud Coverup
TheStreet.com
Thu, 11/4/10 - 11:33 am
MannKind
fraud
Afrezza
inhaled insulin
diabetes
American Diabetes Association Announces New Research Grant Program in Bariatric Surgery
Thu, 11/4/10 - 11:33 am
diabetes
bariatric surgery
Covidien
Ethicon-Endo Surgery
funding
type 2 diabetes
Lilly CEO Calls for a 'Wave of Invention' to Reduce the Toll of Diabetes
Yahoo
Wed, 11/3/10 - 10:49 am
Pharma CEOs
Eli Lilly
diabetes
John Lechleiter
Biodel Needs a Big Buddy, and Fast
Minyanville
Mon, 11/1/10 - 07:50 pm
diabetes
Biodel
Linjeta
FDA Issues Complete Response Letter to Biodel Regarding New Drug Application for Linjeta
Yahoo
Mon, 11/1/10 - 08:55 am
FDA
Biodel
Linjeta
insulin
diabetes
A Disappointing Diabetes-Drug Development
WSJ Online
Wed, 10/27/10 - 04:00 pm
diabetes
Phenomix
Forest Labs
Amylin Pharmaceuticals: Will it Navigate the Rough Waters Ahead?
Seeking Alpha
Tue, 10/26/10 - 11:54 am
Amylin
diabetes
exanitide
Lilly's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin
Bloomberg
Sat, 10/23/10 - 12:39 pm
Eli Lilly
diabetes
Amylin
Pfizer
Sanofi
Cephalon
The Top 10 Phase III Failures of 2010
Fierce Biotech
Fri, 10/22/10 - 11:36 am
clinical trials
dimebon
Medivation
Pfizer
ocrelizumab
Roche
rheumatoid arthritis
taspoglutide
diabetes
Ipsen
semagacestat
Eli Lilly
ASA404
Antisoma
Novartis
Novelos Therapeutics
AstraZeneca
zibotentan
vicriviroc
Merck
Recentin
Vical
Sanofi
Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin
Bloomberg
Fri, 10/22/10 - 07:26 am
diabetes
Amylin
Eli Lilly
Cephalon
M&A
Endo
Bydureon
Byetta
What Amylin's Diabetes Treatment Complete Response Letter Means for Avanir
Seeking Alpha
Thu, 10/21/10 - 11:07 am
Amylin
diabetes
Alkermes
Eli Lilly
Bydureon
New Diabetes Device Next Step in the Quest for Closed-Loop System
Thu, 10/21/10 - 08:57 am
diabetes
hypoglycemia
Medtronic
insulin delivery
Lilly, MacroGenics Say Diabetes Treatment Misses Goal in Late-Stage Study
Bloomberg
Wed, 10/20/10 - 09:38 pm
diabetes
Macrogenics
Eli Lilly
teplizumab
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Bloomberg
Wed, 10/20/10 - 10:46 am
Amylin
Eli Lilly
Alkermes
FDA
Bydureon
diabetes
One More Reason That Lilly Must Do A Deal, Fast
Pharmalot
Wed, 10/20/10 - 09:32 am
Eli Lilly
M&A
Amylin
Bydureon
diabetes
Alkermes
Alkermes' Drug Approval On Tap
Investors.com
Tue, 10/19/10 - 10:28 pm
Alkermes
FDA
Bydureon
diabetes
Eli Lilly
Amylin
Byetta
Vivitrol
alcoholism
Lilly, Novo tops among diabetes doctors
Fierce Pharma
Tue, 10/19/10 - 06:48 pm
Eli Lilly
Novo Nordisk
diabetes
physicians
Pfizer Goes Super-Generic
Forbes
Mon, 10/18/10 - 11:09 am
Pfizer
generics
insulin
Biocon
diabetes
M&A

Pages